These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 528697)

  • 1. Sulfones and sulfonamides in dermatology today.
    Lang PG
    J Am Acad Dermatol; 1979 Dec; 1(6):479-92. PubMed ID: 528697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone and sulfapyridine.
    Paniker U; Levine N
    Dermatol Clin; 2001 Jan; 19(1):79-86, viii. PubMed ID: 11155588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone and sulfapyridine therapy of pemphigoid diseases.
    Rogers RS
    Australas J Dermatol; 1986 Aug; 27(2):58-63. PubMed ID: 3555440
    [No Abstract]   [Full Text] [Related]  

  • 4. [Side effects of treatment with sulfones].
    Revuz J; Hornac P
    LARC Med; 1981 Dec; 1(3):68-70. PubMed ID: 6298511
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic bullous disease of childhood--aspects of management.
    Rogers M; Bartlett B; Walder B; Cains G
    Australas J Dermatol; 1982 Aug; 23(2):62-9. PubMed ID: 6758754
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hematologic effects of dapsone (Disulone)].
    Bordessoule D; Liozon E; Cransac M; Bonnetblanc JM; Vidal E; Weinbreck P; Liozon F
    Rev Med Interne; 1989; 10(6):531-6. PubMed ID: 2488504
    [No Abstract]   [Full Text] [Related]  

  • 7. Sulfonamides and sulfones in dermatologic therapy.
    Bernstein JE; Lorincz AL
    Int J Dermatol; 1981 Mar; 20(2):81-8. PubMed ID: 7012050
    [No Abstract]   [Full Text] [Related]  

  • 8. Dapsone and sulfapyridine.
    Uetrecht J
    Clin Dermatol; 1989; 7(3):111-20. PubMed ID: 2680014
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of human skin proteinases by chloroquine, dapsone and sulfapyridine.
    Fräki JE; Hopsu-Havu VK
    Arch Dermatol Res (1975); 1977 Jul; 259(1):113-5. PubMed ID: 900989
    [No Abstract]   [Full Text] [Related]  

  • 10. Bullous pemphigoid responding to sulfapyridine and the sulfones.
    Person JR; Rogers RS
    Arch Dermatol; 1977 May; 113(5):610-5. PubMed ID: 324403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone.
    Wolf R; Matz H; Orion E; Tuzun B; Tuzun Y
    Dermatol Online J; 2002 Jun; 8(1):2. PubMed ID: 12165212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone and sulfones in dermatology: overview and update.
    Zhu YI; Stiller MJ
    J Am Acad Dermatol; 2001 Sep; 45(3):420-34. PubMed ID: 11511841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic side-effects of dapsone.
    Wilson JR; Harris JW
    Ohio State Med J; 1977 Aug; 73(8):557-60. PubMed ID: 887243
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypersensitivity pneumonia caused by sulfonamides].
    von Breska B; Criée CP; Hüttemann U
    Dtsch Med Wochenschr; 1990 Jan; 115(4):139-41. PubMed ID: 2298130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What do we know today about diaminodiphenylsulfone?].
    Golusin Z; Poljacki M; Preveden R; Stojanović S; Rajić N
    Med Pregl; 2000; 53(7-8):369-72. PubMed ID: 11214480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative use of dapsone.
    Wozel VE
    Dermatol Clin; 2010 Jul; 28(3):599-610. PubMed ID: 20510768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dapsone in skin diseases].
    Zalewska A; Napieralska-Krzysiek E
    Pol Merkur Lekarski; 2003 Nov; 15(89):484-6. PubMed ID: 14969150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfapyridine and sulfone type drugs in dermatology.
    LORINCZ AL; PEARSON RW
    Arch Dermatol; 1962 Jan; 85():2-16. PubMed ID: 14466713
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe dapsone hypersensitivity syndrome.
    Sener O; Doganci L; Safali M; Besirbellioglu B; Bulucu F; Pahsa A
    J Investig Allergol Clin Immunol; 2006; 16(4):268-70. PubMed ID: 16889287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfapyridine and sulfones decrease glycosaminoglycans viscosity in dermatitis herpetiformis, ulcerative colitis, and pyoderma gangrenosum.
    Stone OJ
    Med Hypotheses; 1990 Feb; 31(2):99-103. PubMed ID: 2182989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.